23 results found.

Attention-deficit/Hyperactivity Disorder Clinical Trial using Methylphenidate (Concerta)

National Taiwan University Hospital - Recruiting 7 years to 16 years.
- A Study to Identify the Peripheral Biomarkers of Symptomatology, Neurocognitive Functions, and Medication Response in Attention Deficit Hyperactivity Disorder.
Methylphenidate (Concerta)

Attention Deficit Hyperactivity Disorder Clinical Trial using Text- Messaging; Treatment as usual

Massachusetts General Hospital - Recruiting 6 years to 12 years.
- Text Messaging Adherence to Stimulant Medication.
Text- Messaging; Treatment as usual

Mood Disorder, Mental Disorder Diagnosed in Childhood, Attention Clinical Trial using Citalopram; Methylphenidate

National Institutes of Health Clinical Center (CC) - Recruiting 7 years to 17 years.
- A Controlled Trial of Citalopram Added to Methylphenidate in Youth With Severe Mood Dysregulation.
Citalopram; Methylphenidate

Attention Deficit Disorder With Hyperactivity, Attention Deficit Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 4 years to 8 years.
- Near Infra-Red Spectroscopy (NIRS) in Neurodevelopmental Disorders and Typically Developing Children.

Attention Deficit Disorder With Hyperactivity Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 3 years or older.
- The Neurobehavioral, Environmental and Genetic Factors Impacting the Clinical Course of Attention Deficit Hyperactivity Disorder.

Attention Deficit Hyperactivity Disorder Clinical Trial using Computerized Progressive Attention Training; Sham Comparator Cognitive Training

Children's Hospital Medical Center, Cincinnati - Recruiting 7 years to 12 years.
- Efficacy of a Cognitive Training Intervention for Children With ADHD.
Computerized Progressive Attention Training; Sham Comparator Cognitive Training

Attention-deficit/Hyperactivity Disorder Clinical Trial using Lisdexamfetamine dimesylate; Methylphenidate Hydrochloride; Placebo

Shire Development LLC - Recruiting 13 years to 17 years.
- A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSEr) Compared With OROS-MPH (CONCERTAr) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD).
Lisdexamfetamine dimesylate; Methylphenidate Hydrochloride; Placebo

Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial using AR11

Arbor Pharmaceuticals, Inc. - Recruiting 6 years to 12 years.
- A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom.
AR11

Attention-deficit/Hyperactivity Disorder Clinical Trial using Methylphenidate

Florida International University - Recruiting 6 years to 12 years.
- Examining Tolerance to CNS Stimulants in ADHD.
Methylphenidate

Attention Deficit Disorder With Hyperactivity Clinical Trial

University of California, Los Angeles - Recruiting 5 years to 12 years.
- Leveraging Mobile Health Technology to Optimize Early Stimulant Medication Treatment: A Feasibility Pilot.

Attention Deficit Hyperactivity Disorder Clinical Trial using Ritalin; Placebo

McGill University - Recruiting 6 years to 12 years.
- .
Ritalin; Placebo

ADHD, or Attention Deficit Hyperactivity Disorder Clinical Trial using Naltrexone; Placebo

Massachusetts General Hospital - Recruiting 18 years to 55 years.
- A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder.
Naltrexone; Placebo

Attention Deficit Hyperactivity Disorder Clinical Trial

National Taiwan University Hospital - Recruiting 17 years to 24 years.
- Adult Outcome of Children With Attention-deficit/Hyperactivity Disorder.

Attention-Deficit/Hyperactivity Disorder Clinical Trial using EMS 7500 Digital Muscle Stimulator

University of California, Los Angeles - Recruiting 9 years to 14 years.
- An Eight-Week, Open Trial Pilot Investigation of Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD).
EMS 7500 Digital Muscle Stimulator

Attention-Deficit Hyperactivity Disorder Clinical Trial using Cogmed Working Memory Training Program

University of Toronto - Recruiting 18 years to 35 years.
- Working Memory Training in Attention-Deficit/Hyperactivity Disorder: Neural Mechanisms of Change.
Cogmed Working Memory Training Program

Attention Deficit Disorder With Hyperactivity Clinical Trial using Valproate; Risperidone; Placebo; Stimulant medication; Behavioral family counseling

National Institute of Mental Health (NIMH) - Recruiting 6 years to 12 years.
- Adjunctive Treatment With Divalproex or Risperidone for Aggression Refractory to Stimulant Monotherapy Among Children With ADHD.
Valproate; Risperidone; Placebo; Stimulant medication; Behavioral family counseling

Attention Deficit Hyperactivity Disorder Clinical Trial

National Taiwan University Hospital - Recruiting 18 years to 50 years.
- The Effectiveness of Atomoxetine on Brain Imaging, Neuropsychological, and Social Functions in Adults With Attention Deficit/Hyperactivity Disorder.

ADHD, or Attention Clinical Trial using Cognitive training; Cognitive training-placebo

University of California, Davis - Recruiting 7 years to 14 years.
- Pilot Testing of Cognitive Training on Academic Task Performance in Children With Attention-deficit/Hyperactivity Disorder.
Cognitive training; Cognitive training-placebo

Bipolar Disorder Clinical Trial using Neurocognitive Tasks; EEG; fMRI

National Institute of Mental Health (NIMH) - Recruiting 7 years to 17 years.
- Examining Neurocognitive Profiles of Bipolar Disorder and Attention-Deficit Hyperactivity Disorder.
Neurocognitive Tasks; EEG; fMRI

ADHD, St John`s Wort, Valerian Extract, Efficacy, or Safety Clinical Trial using St. John's Wort/Valerian Extract; Placebo

Johannes Gutenberg University Mainz - Recruiting 6 years to 17 years.
- Efficacy and Safety of St. John's Wort/Valerian Extract (Sedariston Concentrate) Versus Placebo in Children and Adolescents With Attention Deficit/Hyperactivity Disorder (ADHD).
St. John's Wort/Valerian Extract; Placebo

Attention Deficit Disorder With Hyperactivity Clinical Trial using Atomoxetine; Methylphenidate

National Institute of Mental Health (NIMH) - Recruiting 6 years to 17 years.
- Measuring and Predicting Response to Atomoxetine and Methylphenidate.
Atomoxetine; Methylphenidate

Conduct Disorder, Oppositional Defiant Disorder, or Attention Def Clinical Trial using Community mental health consultation model program; Treatment as usual (TAU)

National Institute of Mental Health (NIMH) - Recruiting 5 years to 12 years.
- Mental Health Services & Predictors of Learning in Urban Schools.
Community mental health consultation model program; Treatment as usual (TAU)

Attention Deficit Hyperactivity Disorder, Autistic Disorder, or D Clinical Trial

Sheba Medical Center - Recruiting 4 years to 10 years.
- Characterization of Executive Functions and Patterns of Eye Movements in Children With Developmental Disabilities.